Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1583  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


ORIGINAL ARTICLE
Year : 2020  |  Volume : 12  |  Issue : 5  |  Page : 378-381

Evaluation of efficacy of pilocarpine and bethanechol in xerostomic denture wearers


1 Department of Dentistry, Patna Medical College and Hospital, Patna, Bihar, India
2 Department of Prosthodontics, Crown, Bridge, and Implantology, Patna Dental College and Hospital, Patna, Bihar, India
3 Consultant in Oral Medicine and Radiology, Patna, Bihar, India
4 Department of Pharmacology, Patna Medical College and Hospital, Patna, Bihar, India
5 Department of Oral and Maxillofacial Pathology, Malla Reddy Institute of Dental Sciences, Jeedimetla, Hyderabad, India
6 Department of Oral Pathology, Army College of Dental Sciences, Secunderbad, Telangana, India

Correspondence Address:
Rohit Singh
Department of Prosthodontics, Crown Bridge, and Implantology, Patna Dental College and Hospital, Patna, Bihar.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jpbs.JPBS_111_20

Rights and Permissions

Aim: The aim of this study was to evaluate effectiveness of bethanechol and pilocarpine among xerostomic denture wearers. Materials and Methods: This in vitro study was conducted in 60 complete denture wearers of both genders. For assessment of salivary flow, resting saliva and stimulated saliva were collected. Patients were split into two groups consisting of 30 patients each. Pilocarpine was given to patients in group I and patients in group II received bethanechol. Salivary flow was measured at baseline, after 2 weeks, and after 4 weeks. Results: The mean whole resting saliva in patients of group I was 0.61 mg/mL and in that of group II was 0.65 mg/mL. The mean whole stimulated saliva in patients of group I was 1.35 mg/mL and in group II it was 1.51 mg/mL. The mean whole resting saliva after 2 weeks in patients of group I was 0.83 mg/mL and in group II was 0.92 mg/mL. Whole stimulated saliva in patients of group I was 1.67 mg/mL, and in patients of group II it was 1.86 mg/mL. The difference noted was significant (P < 0.05). The mean whole resting saliva after 4 weeks in patients of group I was 1.23 mg/mL and in that of group II was 1.43 mg/mL. Whole stimulated saliva in patients of group I was 1.98 mg/mL and in patients of group II it was 2.04 mg/mL. Conclusion: Authors found that both agents were effective in increasing salivary secretions. However, pilocarpine is a more effective sialagogue as compared to bethanechol in completely edentulous patients with xerostomia.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed42    
    Printed0    
    Emailed0    
    PDF Downloaded3    
    Comments [Add]    

Recommend this journal